Location History:
- Machida, JP (1990 - 1991)
- Sagamihara, JP (1997)
- Shizuoka, JP (2002)
- Shunto-gun, JP (2002)
- Sizuoka, JP (2003)
- Tokyo, JP (1992 - 2005)
Company Filing History:
Years Active: 1990-2005
Title: Mitsunobu Hara: Innovator in Pharmaceutical Chemistry
Introduction
Mitsunobu Hara is a prominent inventor based in Machida, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with antitumor properties. With a total of 10 patents to his name, Hara's work has the potential to impact the treatment of various diseases.
Latest Patents
Hara's latest patents include innovative compounds such as piperidine derivatives. These substituted piperidine derivatives feature at least one six-membered ring substituent and exhibit antitumor activity, making them valuable as pharmaceuticals. Another notable invention is an agent for inducing apoptosis, which comprises a tetrocarcin derivative. This agent is designed to be used as a medicament for the preventive and therapeutic treatment of diseases associated with increased expression of Bcl-2 family proteins, including cancers and AIDS.
Career Highlights
Throughout his career, Mitsunobu Hara has worked with notable companies in the pharmaceutical industry, including Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Kogyo Kabushiki Kaisha. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Hara has collaborated with esteemed colleagues such as Hirofumi Nakano and Yutaka Kanda. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking inventions.
Conclusion
Mitsunobu Hara's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, particularly in the fight against cancer and other serious diseases.